156 related articles for article (PubMed ID: 1362703)
1. Changes on distribution of CD4+/CD45RA- and CD8+/CD11- cells in tumor-infiltrating lymphocytes of renal cell carcinoma associated with tumor progression.
Igarashi T; Murakami S; Takahashi H; Matsuzaki O; Shimazaki J
Eur Urol; 1992; 22(4):323-8. PubMed ID: 1362703
[TBL] [Abstract][Full Text] [Related]
2. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
3. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
Kowalczyk D; Skorupski W; Kwias Z; Nowak J
Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
6. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
[TBL] [Abstract][Full Text] [Related]
7. [Two-color flow cytometric analysis of lymphocytic subsets in renal cell carcinoma].
Nagase Y; Moriyama N; Kurimoto S; Hosaka Y; Tajima A; Higashihara E; Aso Y
Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):281-8. PubMed ID: 8121110
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
9. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P
Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin Y; Janseens J; Vandepitte J; Vandenbrande J; Opdebeek L; Raus J
Anticancer Res; 1992; 12(5):1463-6. PubMed ID: 1332579
[TBL] [Abstract][Full Text] [Related]
11. Helper T cells infiltrating human renal cell carcinomas have the phenotype of activated memory-like T lymphocytes.
Alexander RB; Fitzgerald EB; Mixon A; Carter CS; Jakobsen M; Cohen PA; Rosenberg SA
J Immunother Emphasis Tumor Immunol; 1995 Jan; 17(1):39-46. PubMed ID: 7728304
[TBL] [Abstract][Full Text] [Related]
12. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.
Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD
Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183
[TBL] [Abstract][Full Text] [Related]
13. Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Bukowski RM; Sharfman W; Murthy S; Rayman P; Tubbs R; Alexander J; Budd GT; Sergi JS; Bauer L; Gibson V
Cancer Res; 1991 Aug; 51(16):4199-205. PubMed ID: 1868441
[TBL] [Abstract][Full Text] [Related]
14. Increased frequencies of the CD29 and CD57 markers and decreased frequency of CD45RA within CD4+ and CD8+ subsets after allogeneic bone marrow transplantation in man.
Møller J; Dickmeiss E; Ryder LP; Jacobsen N; Svejgaard A
Scand J Immunol; 1991 May; 33(5):499-504. PubMed ID: 1709516
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative analysis of Th1 and Th2 cytokine expression in CD3+, CD4+, and CD8+ renal-cell-carcinoma-infiltrating lymphocytes.
Elsässer-Beile U; Grussenmeyer T; Gierschner D; Schmoll B; Schultze-Seemann W; Wetterauer U; Schulte Mönting J
Cancer Immunol Immunother; 1999 Jul; 48(4):204-8. PubMed ID: 10431690
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
20. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
